Recruiting NA Cognitive Intervention to Promote Healthy Development of Executive Function (EF) Skills in Young Children

New treatment option for Cognitive Intervention to Promote Healthy Development of Executive...

Official title Parent-Child EF Intervention

ClinicalTrials.gov ID: NCT06924307

What this study is testing

What it's testing
Koronis Biomedical Technologies Corporation (KBT) is developing a cognitive intervention to promote healthy development of Executive Function (EF) skills in young children by leveraging a smartphone-based training regime designed for parents.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 2 to 5. Healthy volunteers may be eligible.

You may be able to join if

  • Children ages 2-5 years.
  • Caregivers/guardian of the participating child.

You likely can't join if

  • Children with physical disabilities affecting vision, hearing, or basic mobility.
  • Children with severe developmental delays or disorders
  • Parents or caregivers who cannot read and understand English

The study team makes the final eligibility decision.

Where it's taking place

  • Minneapolis, Minnesota, United States
  • New York, New York, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 2 years to 5 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Minneapolis, Minnesota, United States; New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.